The impact of tranexamic acid on mortality in injured patients with hyperfibrinolysis

Journal of Trauma and Acute Care Surgery

Volumn 78, Issue 5, 2015, Pages 905-911

  Harvin, John A ^a   Peirce, Charles A ^a   Mims, Mark M ^a   Hudson, Jessica A ^a   Podbielski, Jeanette M ^a   Wade, Charles E ^a   Holcomb, John B ^a   Cotton, Bryan A ^a  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

Hyperfibrinolysis; mortality; tranexamic acid; trauma; TXA

Indexed keywords

TRANEXAMIC ACID; ANTIFIBRINOLYTIC AGENT;

ADULT; ALKALOSIS; ARTICLE; BLOOD CLOTTING DISORDER; DRUG USE; ERYTHROCYTE CONCENTRATE; ERYTHROCYTE TRANSFUSION; FEMALE; HOSPITAL ADMISSION; HUMAN; HYPERFIBRINOLYSIS; HYPOTENSION; INJURY; INJURY SCALE; INJURY SEVERITY; INSTITUTIONAL REVIEW; MAJOR CLINICAL STUDY; MALE; MORTALITY; PLASMA TRANSFUSION; PRIORITY JOURNAL; SHOCK; SURVIVAL; SYSTOLIC BLOOD PRESSURE; THROMBOELASTOGRAPHY; TREATMENT OUTCOME; VENOUS THROMBOEMBOLISM; CLINICAL TRIAL; COMPLICATION; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DOPPLER FLOWMETRY; DOSE RESPONSE; EMERGENCY HEALTH SERVICE; FOLLOW UP; INTRAVENOUS DRUG ADMINISTRATION; MIDDLE AGED; MULTICENTER STUDY; RANDOMIZED CONTROLLED TRIAL; RETROSPECTIVE STUDY; RISK; THROMBOPHILIA; TRENDS; UNITED STATES; WOUNDS AND INJURIES; YOUNG ADULT;

ADULT; ANTIFIBRINOLYTIC AGENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FOLLOW-UP STUDIES; HOSPITAL MORTALITY; HUMANS; INFUSIONS, INTRAVENOUS; INJURY SEVERITY SCORE; MALE; MIDDLE AGED; ODDS RATIO; RETROSPECTIVE STUDIES; THROMBELASTOGRAPHY; THROMBOPHILIA; TOMOGRAPHY, X-RAY COMPUTED; TRANEXAMIC ACID; TRAUMA CENTERS; TREATMENT OUTCOME; ULTRASONOGRAPHY, DOPPLER; UNITED STATES; VENOUS THROMBOEMBOLISM; WOUNDS AND INJURIES; YOUNG ADULT;

EID: 84928919876     PISSN: 21630755     EISSN: 21630763     Source Type: Journal    
DOI: 10.1097/TA.0000000000000612     Document Type: Article

References (16)

1. Cothren CC, Moore EE, Hedegaard HB, Meng K. Epidemiology of urban trauma deaths: a comprehensive reassessment 10 years later. World J Surg. 2007;31(7):1507-1511.
2. Gunter OL Jr, Au BK, Isbell JM, Mowery NT, Young PP, Cotton BA. Optimizing outcomes in damage control resuscitation: identifying blood product ratios associated with improved survival. J Trauma. 2008;65(3):527-534.
3. Brohi K, Singh J, Heron M, Coats T. Acute traumatic coagulopathy. J Trauma. 2003;54(6):1127-1130.
4. Niles SE, McLaughlin DF, Perkins JG, Wade CE, Li Y, Spinella PC, Holcomb JB. Increased mortality associated with the early coagulopathy of trauma in combat casualties. J Trauma. 2008;64(6):1459-1463.
5. Cotton BA, Reddy N, Hatch QM, LeFebvre E,Wade CE, Kozar RA, Gill BS, Albarado R, McNutt MK, Holcomb JB. Damage control resuscitation is associated with a reduction in resuscitation volumes and improvement in survival in 390 damage control laparotomy patients. Ann Surg. 2011;254(4):598-605.
6. Moore EE. Thomas G. OrrMemorial Lecture. Staged laparotomy for the hypothermia, acidosis, and coagulopathy syndrome.AmJ Surg. 1996;172(5):405-410.
7. Kashuk JL, Moore EE, Sawyer M,Wohlauer M, Pezold M, Barnett C, Biffl WL, BurlewCC, Johnson JL, Sauaia A. Primary fibrinolysis is integral in the pathogenesis of the acute coagulopathy of trauma. Ann Surg. 2010;252(3):434-442.
8. CRASH-2 trial collaborators. Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial. Lancet. 2010;376(9734):23-32.
9. CRASH-2 trial collaborators, Roberts I, Shakur H, Afolabi A, Brohi K, Coats T, Dewan Y, Gando S, Guyatt G, Hunt BJ, Morales C, et al. The importance of early treatment with tranexamic acid in bleeding trauma patients: an exploratory analysis of the CRASH-2 randomized controlled trial. Lancet. 2011;377(9771):1096-1101.
10. Napolitano LM, Cohen MJ, Cotton BA, Schreiber MA, Moore EE. Tranexamic acid in trauma: how should we use it? J Trauma Acute Care Surg. 2013;74(6):1575-1586.
11. Holcomb JB, Minei KM, Scerbo ML, Radwan ZA, Wade CE, Kozar RA, Gill BS, Albarado R, McNutt MK, Khan S, et al. Admission rapid thrombelastography (r-TEG) can replace conventional coagulation tests in the emergency department: experience with 1974 consecutive trauma patients. Ann Surg. 2012;256(3):476-486.
12. Cotton BA, Harvin JA, Kostousouv V, Minei KM, Radwan ZA, Schöchl H, Wade CE, Holcomb JB, Matijevic N. Hyperfibrinolysis at admission is an uncommon but highly lethal event associated with shock and prehospital fluid administration. J Trauma Acute Care Surg. 2012;73(2):365-370.
13. Chapman MP, Moore EE, Ramos CR, Ghasabyan A, Harr JN, Chin TL, Stringham JR, Sauaia A, Silliman CC, Banerjee A. Fibrinolysis greater than 3 is the critical value for initiation of antifibrinolytic therapy. J Trauma Acute Care Surgery. 2013;75(6):961-967.
14. Hosmer DW, Lemeshow S. Applied Logistic Regression. New York, NY: Wiley; 2000.
15. Valle EJ, Allen CJ, Van Haren RM, Jouria JM, Li H, Livingstone AS, Namias N, Schulman CI, Proctor KG. Do all trauma patients benefit from tranexamic acid? J Trauma Acute Care Surg. 2014;76(6):1373-1378.
16. Moore HB, Moore EE, Gonzalez E, Chapman MP, Chin TL, Silliman CC, Banerjee A, Sauaia A. Hyperfibrinolysis, physiologic fibrinolysis, and fibrinolysis shutdown: the spectrum of postinjury fibrinolysis and relevance to antifibrinolytic therapy. J Trauma Acute Care Surg. 2014;77(6):811-817.